Ulf Staginnus

VP International Market Access & Pricing at Blueprint Medicines

Speaker

Ulf Staginnus is a recognized global Market Access, Health Economics, Real-World Evidence and Pricing leader with +25 years' international experience in the pharma & biotech industry. He has worked with numerous renowned pharma groups, including big pharma, small and medium-sized and start-up companies, and also established a consulting firm that advises pharma and biotech clients with respect to product pricing, health technology valuations and market access initiatives. Ulf holds a Master in Economics from the University Bayreuth, Germany. He is a regular speaker on access, pricing and health economics related matters and the co-author of “The Future of Health Economics”, published by Routledge, October 2016.